Nanoparticle Defense for Agrichemical Exposures

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$158,919.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
1R43ES022125-01
Award Id:
n/a
Agency Tracking Number:
R43ES022125
Solicitation Year:
2012
Solicitation Topic Code:
NIEHS
Solicitation Number:
PA11-096
Small Business Information
910 Technology Blvd STE G, Bozeman, MT, 59718-
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
606162084
Principal Investigator:
JON NAGY
(406) 586-8420
jon.nagy@nagyconsult.com
Business Contact:
CHARLES THOMPSON
(406) 549-0675
charles.thompson@ateristech.com
Research Institute:
Stub




Abstract
DESCRIPTION (provided by applicant): This Phase I SBIR project seeks to develop specialized protein-polymer nanoparticles that are engineered to a therapeutic drug to counter the ill effects following exposure to organophosphate (OP) insecticides. The concept for these nanoparticles is based on 'customized, triggered-release' in which the membrane of a polymerized liposome nanoparticle (PLN) displays functional acetylcholinesterase, the primary target for OPs, while a therapeutic cargo is encapsulated (e.g., oxime). During an OP exposure, the AChE is inhibited (the same as exogenous ChE) to cause protein changes that later the polymeric nanoparticle membrane allowing the oxime cargo (various mechanisms possible) to be released and immediately available to restore exogenous ChE. Because the PLNs are customized and specific to OPs, PLN-AChE nanoparticles will not produce unwanted, high concentrations of the therapeutic agents in the body without OP exposure. In this application, we will develop and subsequentlyshow that AChE-PLNs can be generated with functional enzyme and are selectively inhibited by organophosphates (OP). We will further demonstrate that small molecule cargo can be loaded and stored in functional AChE-PLNs that reaction with OPs releases theentrapped cargo. We will produce 25 mg each of three functional, intact ChE-PLNs in readiness for the Phase II portion of this RandD project. PUBLIC HEALTH RELEVANCE: Citizens can be exposed to organophosphate (OP) insecticides via domestic application, aerial spraying, crops, as a pediculicide, and through the food chain. Accidental exposure to OP- containing pesticides can cause many tiers of toxicity, injury or be fatal to humans. For decades, only high-level exposures to OPs receive medical attention because low, chronic exposures have gone unchecked largely because they can asymptomatic, usually manifesting illnesses through accumulated exposures. If therapeutic measures could be available through a preventative process and highly specific toward OP exposures, a reduction in short- and long- term ill health effects could be expected.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government